Healthcare -
Biotechnology - NYSE - CH
$ 1.83
4.57 %
$ 177 M
Market Cap
-0.77
P/E
Price Target
Average
524.51%
Revenue Forecast
Estimate
56.03%
EBIT
Estimate
7.01%
Net Income
Estimate
56.25%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
ADC Therapeutics SA
Wall Street analysts predict an average 1-year price target for ADCT of $11.4 , with forecasts ranging from
a
low of
$7 to a high of $20 .
ADCT Lowest Price Target
Wall Street Target
7 USD
282.51%
ADCT Average Price Target
Wall Street Target
11.4 USD
524.51%
ADCT Highest Price Target
Wall Street Target
20 USD
992.90%
REVENUE FORECAST
Revenue Forecast Chart ADCT
EBIT FORECAST
EBIT Forecast Chart ADCT
NET INCOME FORECAST
Net Income Chart ADCT